A novel vaccine p846 encoding Rv3615c, Mtb10.4, and Rv2660c elicits robust immune response and alleviates lung injury induced by Mycobacterium infection

References

• WHO. Global tuberculosis control. Geneva,Switzerland, 2013.
   Google Scholar
• Lu J, Wang C, Zhou Z, Zhang Y, Cao T, Shi C, Chen Z, Chen L, Cai C, Fan X. Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein. Clin Dev Immunol 2011; 2011:617892; http://dx.doi.org/10.1155/2011/617892; PMID: 21461375
   PubMed Web of Science ®Google Scholar
• Kozakiewicz L, Phuah J, Flynn J, Chan J. The role of B cells and humoral immunity in Mycobacterium tuberculosis infection. Adv Exp Med Biol 2013; 783:225 - 50; http://dx.doi.org/10.1007/978-1-4614-6111-1_12; PMID: 23468112
   PubMed Web of Science ®Google Scholar
• Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994; 271:698 - 702; http://dx.doi.org/10.1001/jama.1994.03510330076038; PMID: 8309034
   PubMed Web of Science ®Google Scholar
• Ottenhoff TH, Kaufmann SH. Vaccines against tuberculosis: where are we and where do we need to go?. PLoS Pathog 2012; 8:e1002607; http://dx.doi.org/10.1371/journal.ppat.1002607; PMID: 22589713
   PubMed Web of Science ®Google Scholar
• Bruns H, Meinken C, Schauenberg P, Härter G, Kern P, Modlin RL, Antoni C, Stenger S. Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans. J Clin Invest 2009; 119:1167 - 77; http://dx.doi.org/10.1172/JCI38482; PMID: 19381021
   PubMed Web of Science ®Google Scholar
• Palma C, Schiavoni G, Abalsamo L, Mattei F, Piccaro G, Sanchez M, Fernandez C, Singh M, Gabriele L. Mycobacterium tuberculosis PstS1 amplifies IFN-γ and induces IL-17/IL-22 responses by unrelated memory CD4+ T cells via dendritic cell activation. Eur J Immunol 2013; 43:2386 - 97; http://dx.doi.org/10.1002/eji.201243245; PMID: 23719937
   PubMed Web of Science ®Google Scholar
• Bold TD, Ernst JD. CD4+ T cell-dependent IFN-γ production by CD8+ effector T cells in Mycobacterium tuberculosis infection. J Immunol 2012; 189:2530 - 6; http://dx.doi.org/10.4049/jimmunol.1200994; PMID: 22837486
   PubMed Web of Science ®Google Scholar
• Aagaard C, Hoang T, Dietrich J, Cardona PJ, Izzo A, Dolganov G, Schoolnik GK, Cassidy JP, Billeskov R, Andersen P. A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat Med 2011; 17:189 - 94; http://dx.doi.org/10.1038/nm.2285; PMID: 21258338
   PubMed Web of Science ®Google Scholar
• Davila J, McNamara LA, Yang Z. Comparison of the predicted population coverage of tuberculosis vaccine candidates Ag85B-ESAT-6, Ag85B-TB10.4, and Mtb72f via a bioinformatics approach. PLoS One 2012; 7:e40882; http://dx.doi.org/10.1371/journal.pone.0040882; PMID: 22815851
   PubMedGoogle Scholar
• Langermans JA, Doherty TM, Vervenne RA, van der Laan T, Lyashchenko K, Greenwald R, Agger EM, Aagaard C, Weiler H, van Soolingen D, et al. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Vaccine 2005; 23:2740 - 50; http://dx.doi.org/10.1016/j.vaccine.2004.11.051; PMID: 15780721
   PubMed Web of Science ®Google Scholar
• Niu H, Hu L, Li Q, Da Z, Wang B, Tang K, Xin Q, Yu H, Zhang Y, Wang Y, et al. Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX. Vaccine 2011; 29:9451 - 8; http://dx.doi.org/10.1016/j.vaccine.2011.10.032; PMID: 22024175
   PubMed Web of Science ®Google Scholar
• Dietrich J, Aagaard C, Leah R, Olsen AW, Stryhn A, Doherty TM, Andersen P. Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy. J Immunol 2005; 174:6332 - 9; PMID: 15879133
   PubMed Web of Science ®Google Scholar
• Windish HP, Duthie MS, Misquith A, Ireton G, Lucas E, Laurance JD, Bailor RH, Coler RN, Reed SG. Protection of mice from Mycobacterium tuberculosis by ID87/GLA-SE, a novel tuberculosis subunit vaccine candidate. Vaccine 2011; 29:7842 - 8; http://dx.doi.org/10.1016/j.vaccine.2011.07.094; PMID: 21816196
   PubMed Web of Science ®Google Scholar
• Kamath AT, Feng CG, Macdonald M, Briscoe H, Britton WJ. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect Immun 1999; 67:1702 - 7; PMID: 10085007
   PubMed Web of Science ®Google Scholar
• Mir FA, Kaufmann SH, Eddine AN. A multicistronic DNA vaccine induces significant protection against tuberculosis in mice and offers flexibility in the expressed antigen repertoire. Clin Vaccine Immunol 2009; 16:1467 - 75; http://dx.doi.org/10.1128/CVI.00237-09; PMID: 19656992
   PubMed Web of Science ®Google Scholar
• Yuan W, Dong N, Zhang L, Liu J, Lin S, Xiang Z, Qiao H, Tong W, Qin C. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice. Vaccine 2012; 30:2490 - 7; http://dx.doi.org/10.1016/j.vaccine.2011.06.029; PMID: 21704108
   PubMed Web of Science ®Google Scholar
• West NP, Thomson SA, Triccas JA, Medveczky CJ, Ramshaw IA, Britton WJ. Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis. Vaccine 2011; 29:7759 - 65; http://dx.doi.org/10.1016/j.vaccine.2011.07.109; PMID: 21846485
   PubMed Web of Science ®Google Scholar
• Vita R, Zarebski L, Greenbaum JA, Emami H, Hoof I, Salimi N, Damle R, Sette A, Peters B. The immune epitope database 2.0. Nucleic Acids Res 2010; 38:D854 - 62; http://dx.doi.org/10.1093/nar/gkp1004; PMID: 19906713
   PubMed Web of Science ®Google Scholar
• Boesen H, Jensen BN, Wilcke T, Andersen P. Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect Immun 1995; 63:1491 - 7; PMID: 7890415
   PubMed Web of Science ®Google Scholar
• Millington KA, Fortune SM, Low J, Garces A, Hingley-Wilson SM, Wickremasinghe M, Kon OM, Lalvani A. Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A 2011; 108:5730 - 5; http://dx.doi.org/10.1073/pnas.1015153108; PMID: 21427227
   PubMed Web of Science ®Google Scholar
• Skjøt RL, Oettinger T, Rosenkrands I, Ravn P, Brock I, Jacobsen S, Andersen P. Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens. Infect Immun 2000; 68:214 - 20; http://dx.doi.org/10.1128/IAI.68.1.214-220.2000; PMID: 10603390
   PubMed Web of Science ®Google Scholar
• Skjøt RL, Brock I, Arend SM, Munk ME, Theisen M, Ottenhoff TH, Andersen P. Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family. Infect Immun 2002; 70:5446 - 53; http://dx.doi.org/10.1128/IAI.70.10.5446-5453.2002; PMID: 12228269
   PubMed Web of Science ®Google Scholar
• Billeskov R, Vingsbo-Lundberg C, Andersen P, Dietrich J. Induction of CD8 T cells against a novel epitope in TB10.4: correlation with mycobacterial virulence and the presence of a functional region of difference-1. J Immunol 2007; 179:3973 - 81; PMID: 17785835
   PubMed Web of Science ®Google Scholar
• Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol 2002; 43:717 - 31; http://dx.doi.org/10.1046/j.1365-2958.2002.02779.x; PMID: 11929527
   PubMed Web of Science ®Google Scholar
• Lin PL, Dietrich J, Tan E, Abalos RM, Burgos J, Bigbee C, Bigbee M, Milk L, Gideon HP, Rodgers M, et al. The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection. J Clin Invest 2012; 122:303 - 14; http://dx.doi.org/10.1172/JCI46252; PMID: 22133873
   PubMed Web of Science ®Google Scholar
• Kaufmann SH, Hussey G, Lambert PH. New vaccines for tuberculosis. Lancet 2010; 375:2110 - 9; http://dx.doi.org/10.1016/S0140-6736(10)60393-5; PMID: 20488515
   PubMed Web of Science ®Google Scholar
• Caccamo N, Guggino G, Joosten SA, Gelsomino G, Di Carlo P, Titone L, Galati D, Bocchino M, Matarese A, Salerno A, et al. Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection. Eur J Immunol 2010; 40:2211 - 20; http://dx.doi.org/10.1002/eji.201040455; PMID: 20540114
   PubMed Web of Science ®Google Scholar
• Sutherland JS, Adetifa IM, Hill PC, Adegbola RA, Ota MO. Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur J Immunol 2009; 39:723 - 9; http://dx.doi.org/10.1002/eji.200838693; PMID: 19224636
   PubMed Web of Science ®Google Scholar
• Hesseling AC, Marais BJ, Gie RP, Schaaf HS, Fine PE, Godfrey-Faussett P, Beyers N. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Vaccine 2007; 25:14 - 8; http://dx.doi.org/10.1016/j.vaccine.2006.07.020; PMID: 16959383
   PubMed Web of Science ®Google Scholar
• Ottenhoff TH, Verreck FA, Lichtenauer-Kaligis EG, Hoeve MA, Sanal O, van Dissel JT. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae. Nat Genet 2002; 32:97 - 105; http://dx.doi.org/10.1038/ng0902-97; PMID: 12205477
   PubMed Web of Science ®Google Scholar
• van de Vosse E, Hoeve MA, Ottenhoff TH. Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect Dis 2004; 4:739 - 49; http://dx.doi.org/10.1016/S1473-3099(04)01203-4; PMID: 15567123
   PubMed Web of Science ®Google Scholar
• Ottenhoff TH, Doherty TM, van Dissel JT, Bang P, Lingnau K, Kromann I, Andersen P. First in humans: a new molecularly defined vaccine shows excellent safety and strong induction of long-lived Mycobacterium tuberculosis-specific Th1-cell like responses. Hum Vaccin 2010; 6:1007 - 15; http://dx.doi.org/10.4161/hv.6.12.13143; PMID: 21178394
   PubMed Web of Science ®Google Scholar
• Skeiky YA, Dietrich J, Lasco TM, Stagliano K, Dheenadhayalan V, Goetz MA, Cantarero L, Basaraba RJ, Bang P, Kromann I, et al. Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen. Vaccine 2010; 28:1084 - 93; http://dx.doi.org/10.1016/j.vaccine.2009.10.114; PMID: 19896449
   PubMed Web of Science ®Google Scholar
• Von Eschen K, Morrison R, Braun M, Ofori-Anyinam O, De Kock E, Pavithran P, Koutsoukos M, Moris P, Cain D, Dubois MC, et al. The candidate tuberculosis vaccine Mtb72F/AS02A: Tolerability and immunogenicity in humans. Hum Vaccin 2009; 5:475 - 82; PMID: 19587528
   PubMed Web of Science ®Google Scholar
• McShane H, Pathan AA, Sander CR, Keating SM, Gilbert SC, Huygen K, Fletcher HA, Hill AV. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat Med 2004; 10:1240 - 4; http://dx.doi.org/10.1038/nm1128; PMID: 15502839
   PubMed Web of Science ®Google Scholar
• Radosevic K, Wieland CW, Rodriguez A, Weverling GJ, Mintardjo R, Gillissen G, Vogels R, Skeiky YA, Hone DM, Sadoff JC, et al. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon. Infect Immun 2007; 75:4105 - 15; http://dx.doi.org/10.1128/IAI.00004-07; PMID: 17526747
   PubMed Web of Science ®Google Scholar
• Kao FF, Mahmuda S, Pinto R, Triccas JA, West NP, Britton WJ. The secreted lipoprotein, MPT83, of Mycobacterium tuberculosis is recognized during human tuberculosis and stimulates protective immunity in mice. PLoS One 2012; 7:e34991; http://dx.doi.org/10.1371/journal.pone.0034991; PMID: 22567094
   PubMedGoogle Scholar
• Siddiqui KF, Amir M, Agrewala JN. Understanding the biology of 16 kDa antigen of Mycobacterium tuberculosis: scope in diagnosis, vaccine design and therapy. Crit Rev Microbiol 2011; 37:349 - 57; http://dx.doi.org/10.3109/1040841X.2011.606425; PMID: 21919701
   PubMed Web of Science ®Google Scholar
• Mollenkopf HJ, Grode L, Mattow J, Stein M, Mann P, Knapp B, Ulmer J, Kaufmann SH. Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis. Infect Immun 2004; 72:6471 - 9; http://dx.doi.org/10.1128/IAI.72.11.6471-6479.2004; PMID: 15501778
   PubMed Web of Science ®Google Scholar
• Andersen P. Vaccine strategies against latent tuberculosis infection. Trends Microbiol 2007; 15:7 - 13; http://dx.doi.org/10.1016/j.tim.2006.11.008; PMID: 17141504
   PubMed Web of Science ®Google Scholar
• Karakousis PC, Yoshimatsu T, Lamichhane G, Woolwine SC, Nuermberger EL, Grosset J, Bishai WR. Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice. J Exp Med 2004; 200:647 - 57; http://dx.doi.org/10.1084/jem.20040646; PMID: 15353557
   PubMed Web of Science ®Google Scholar
• Grover A, Ahmed MF, Singh B, Verma I, Sharma P, Khuller GK. A multivalent combination of experimental antituberculosis DNA vaccines based on Ag85B and regions of difference antigens. Microbes Infect 2006; 8:2390 - 9; http://dx.doi.org/10.1016/j.micinf.2006.04.025; PMID: 16962360
   PubMed Web of Science ®Google Scholar
• Yuan W, Dong N, Zhang L, Liu J, Lin S, Xiang Z, Qiao H, Tong W, Qin C. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice. Vaccine 2012; 30:2490 - 7; http://dx.doi.org/10.1016/j.vaccine.2011.06.029; PMID: 21704108
   PubMed Web of Science ®Google Scholar
• Heckman KL, Pease LR. Gene splicing and mutagenesis by PCR-driven overlap extension. Nat Protoc 2007; 2:924 - 32; http://dx.doi.org/10.1038/nprot.2007.132; PMID: 17446874
   PubMed Web of Science ®Google Scholar
• Derrick SC, Yabe IM, Yang A, Morris SL. Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells. Vaccine 2011; 29:2902 - 9; http://dx.doi.org/10.1016/j.vaccine.2011.02.010; PMID: 21338678
   PubMed Web of Science ®Google Scholar
• Ciuffreda D, Comte D, Cavassini M, Giostra E, Bühler L, Perruchoud M, Heim MH, Battegay M, Genné D, Mulhaupt B, et al. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. Eur J Immunol 2008; 38:2665 - 77; http://dx.doi.org/10.1002/eji.200838336; PMID: 18958874
   PubMed Web of Science ®Google Scholar
• Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J, Lederman MM, Benito JM, Goepfert PA, Connors M, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006; 107:4781 - 9; http://dx.doi.org/10.1182/blood-2005-12-4818; PMID: 16467198
   PubMed Web of Science ®Google Scholar
• Dalton DK, Haynes L, Chu CQ, Swain SL, Wittmer S. Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J Exp Med 2000; 192:117 - 22; http://dx.doi.org/10.1084/jem.192.1.117; PMID: 10880532
   PubMed Web of Science ®Google Scholar
• Cai H, Yu DH, Tian X, Zhu YX. Coadministration of interleukin 2 plasmid DNA with combined DNA vaccines significantly enhances the protective efficacy against Mycobacterium tuberculosis. DNA Cell Biol 2005; 24:605 - 13; http://dx.doi.org/10.1089/dna.2005.24.605; PMID: 16225391
   PubMed Web of Science ®Google Scholar
• Capozzo AV, Ramírez K, Polo JM, Ulmer J, Barry EM, Levine MM, Pasetti MF. Neonatal immunization with a Sindbis virus-DNA measles vaccine induces adult-like neutralizing antibodies and cell-mediated immunity in the presence of maternal antibodies. J Immunol 2006; 176:5671 - 81; PMID: 16622037
   PubMed Web of Science ®Google Scholar